FDA grants EUA for COVID-19 drug Ronapreve

MANILA, Philippines — The Food and Drug Administration (FDA) has granted emergency use authorization or EUA for Ronapreve as a treatment against COVID 19.

FDA chief Eric Domingo said the agency approved the use of Ronapreve for mild and moderate COVID-19 cases.

Ronapreve can be given only for COVID patients aged 12 and above, according to Domingo.

Ronapreve is the first monoclonal antibody treatment for the prevention of COVID 19.

Japan was the first country to approve Ronapreve as a treatment against COVID-19.